세계의 자가백신 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Autogenous Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,030,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,267,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,956,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

세계 자가백신 시장 규모는 2025년에 1억 5,210만 달러에 이르고, 2025-2032년의 예측 기간 동안 5.4%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 2억 1,970만 달러에 달할 것으로 예상됩니다.

자가백신은 특정 개체 또는 무리에서 분리된 특정 병원체에 대해 개발된 맞춤형 백신으로, 주로 수의학에서 사용됩니다. 이러한 백신은 가축과 반려동물의 감염병을 통제하는 데 중요한 역할을 하고 있습니다. 시장은 동물병원, 동물보건센터, 농장, 연구소에 공급되며 가금류, 돼지, 소, 양식업 분야에서 수요가 증가하고 있습니다. 시장 확대는 동물 건강에 대한 관심 증가, 규제 유연성, 특히 감염성 질환이 흔한 지역에서 정밀한 수의학적 진료에 대한 관심 증가가 시장 확대에 기여하고 있습니다.

세계 자가백신 시장은 인수공통전염병 및 가축전염병의 발생률 증가, 표적화된 군집별 예방접종의 필요성 등의 주요 요인에 의해 주도되고 있습니다. 이러한 백신은 표준 상용 백신으로는 대응할 수 없는 지역적 병원체 균주에 대응할 수 있는 효과적인 솔루션을 제공합니다. 고품질 동물성 단백질에 대한 수요 증가, 가축의 생산성 향상, 무항생제 육류 제품에 대한 소비자 선호도가 자가백신의 채택을 더욱 촉진하고 있습니다. 규제 당국의 지원과 수의사 및 가축 소유주들 사이에서 맞춤형 질병 관리에 대한 인식이 높아진 것도 시장의 지속적인 성장에 기여하고 있습니다. 또한, 양식 산업의 성장은 종별 자가백신에 대한 새로운 수요를 창출하고 있습니다.

양호한 성장세에도 불구하고, 자가백신 시장은 높은 제조 비용, 백신 개발 기간의 장기화, 제조 방법의 표준화 지연 등 몇 가지 제약 요인에 직면해 있습니다. 이러한 백신은 주문 제작이기 때문에 대량 생산의 확장성이 부족하여 공급망의 효율성과 비용 효율성에 영향을 미칠 수 있습니다. 또한, 지역마다 규제가 다르기 때문에 국제 거래 및 시장 확대에 어려움이 있습니다. 특히 신흥국 시장에서는 소규모 농가에서 자가백신의 혜택에 대한 인식이 부족하고, 병원체 식별을 위한 고급 진단 도구의 가용성이 제한적이라는 점도 시장 침투에 또 다른 장애물이 될 수 있습니다.

자가백신 시장은 병원체 동정, 백신 제형화, 맞춤형 수의학 치료의 기술 발전으로 인해 큰 기회를 창출할 수 있는 시장입니다. 차세대 시퀀싱 및 분자진단 도구의 채택은 병원체 프로파일링의 속도와 정확성을 향상시켜 신속한 백신 개발을 촉진할 것입니다. 항균제 내성 감소에 대한 관심이 높아지고 지속 가능한 축산업으로의 전환은 자가백신의 새로운 성장의 길을 열어줄 것입니다. 동물용 백신 제조업체, 진단 실험실, 학술 기관의 전략적 제휴는 시장 역량을 확대할 가능성이 높습니다. 또한, 특히 신흥 시장에서 동물 위생 이니셔티브에 대한 정부 지원 증가와 수의학 인프라에 대한 투자가 수요를 증가시킬 것으로 예상됩니다.

세계의 자가백신 시장에 대해 조사했으며, 균주 유형별/동물 유형별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위와 정의
• 시장 역학
• 거시경제 요인
• COVID-19의 영향 분석
• 예측 요인 - 관련성과 영향

제3장 부가가치 인사이트

제4장 세계의 자가백신 시장 전망

• 주요 하이라이트
• 시장 규모 분석과 예측
  • 과거 시장 규모 분석, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 2025년-2032년
• 세계의 자가백신 시장 전망 : 주식 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모 분석, 주식 유형별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 주식 유형별, 2025년-2032년
  • 시장의 매력 분석 : 주 유형별
• 세계의 자가백신 시장 전망 : 동물 유형별
  • 서론/주요 조사 결과
  • 과거 시장 규모 분석, 동물 유형별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 동물 유형별, 2025년-2032년
  • 시장의 매력 분석 : 동물 유형별
• 세계의 자가백신 시장 전망 : 최종사용자별
  • 서론/주요 조사 결과
  • 과거 시장 규모 분석, 최종사용자별, 2019년-2024년
  • 현재 시장 규모 분석과 예측, 최종사용자별, 2025년-2032년
  • 시장의 매력 분석 : 최종사용자별

제5장 세계의 자가백신 시장 전망 : 지역별

• 주요 하이라이트
• 과거 시장 규모 분석, 지역별, 2019년-2024년
• 현재 시장 규모 분석과 예측, 지역별, 2025년-2032년
  • 북미
  • 유럽
  • 동아시아
  • 남아시아 및 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제6장 북미의 자가백신 시장 전망

제7장 유럽의 자가백신 시장 전망

제8장 동아시아의 자가백신 시장 전망

제9장 남아시아 및 오세아니아의 자가백신 시장 전망

제10장 라틴아메리카의 자가백신 시장 전망

제11장 중동 및 아프리카의 자가백신 시장 전망

제12장 경쟁 구도

• 시장 점유율 분석, 2025년
• 시장 구조
• 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
  • Phibro Animal Health Corporation,
  • Ceva
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Addison Biological Laboratory
  • Bioveta, as
  • Vaxxinova
  • ARKO Laboratories
  • Dopharma
  • HIPRA
  • Cambridge Technologies
  • IDT Biologika.
  • HYGIEIA BIOLOGICAL LABORATORIES
  • Lohmann Breeders
  • Design Biologix.
  • Deltamune
  • Bimeda(R) Biologicals
  • Others

제13장 부록

LSH

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for Autogenous Vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global autogenous vaccines market from 2025 to 2032.

Key Insights:

• Autogenous Vaccines Market Size (2025E): USD 152.1 Million
• Projected Market Value (2032F): USD 219.7 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 5.4%

Autogenous Vaccines Market - Report Scope:

Autogenous vaccines are custom-made vaccines developed for specific pathogens isolated from a particular individual or herd, primarily used in veterinary medicine. These vaccines play a vital role in controlling infectious diseases in livestock and companion animals when commercial vaccines are ineffective or unavailable. The market serves veterinary clinics, animal health centers, farms, and research laboratories, with increasing demand across poultry, swine, cattle, and aquaculture sectors. Market expansion is fueled by rising concerns over animal health, regulatory flexibility, and growing focus on precision veterinary care, particularly in regions where infectious disease outbreaks are common.

Market Growth Drivers:

The global autogenous vaccines market is driven by key factors including the increasing incidence of zoonotic and livestock diseases and the need for targeted, herd-specific immunization. These vaccines offer an effective solution for managing local strains of pathogens that may not be addressed by standard commercial vaccines. Rising demand for high-quality animal protein, enhanced livestock productivity, and consumer preference for antibiotic-free meat products further push the adoption of autogenous vaccines. Regulatory support and greater awareness among veterinarians and livestock owners regarding customized disease management also contribute to sustained market growth. Additionally, the growing aquaculture industry is generating new demand for species-specific autogenous vaccines.

Market Restraints:

Despite favorable growth trends, the autogenous vaccines market faces several restraints, including high production costs, extended timelines for vaccine development, and limited standardization in manufacturing practices. As these vaccines are tailor-made, the lack of mass production scalability can impact supply chain efficiency and cost-effectiveness. Furthermore, regulatory variations across different regions pose challenges for international trade and market expansion. Inadequate awareness about the benefits of autogenous vaccines among small-scale farmers, particularly in developing regions, and limited availability of advanced diagnostic tools for pathogen identification are additional hurdles to market penetration.

Market Opportunities:

The autogenous vaccines market presents significant opportunities driven by technological advancements in pathogen identification, vaccine formulation, and personalized veterinary care. The adoption of next-generation sequencing and molecular diagnostic tools enhances the speed and accuracy of pathogen profiling, facilitating rapid vaccine development. Growing emphasis on antimicrobial resistance reduction and the shift towards sustainable livestock farming open new growth avenues for autogenous vaccines. Strategic collaborations between veterinary vaccine manufacturers, diagnostic labs, and academic institutions are likely to expand the market's capabilities. Moreover, increasing government support for animal health initiatives and investment in veterinary infrastructure, especially in emerging markets, are expected to boost demand.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the autogenous vaccines market globally?
• Which animal segments and applications are most influenced by autogenous vaccine adoption?
• How are advancements in diagnostics and biotechnology impacting the development of autogenous vaccines?
• Who are the key players contributing to the autogenous vaccines market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global autogenous vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global autogenous vaccines market, including Ceva Sante Animale, Elanco Animal Health, and Phibro Animal Health Corporation, are emphasizing product customization, R&D investment, and geographic expansion to strengthen their market presence. These companies collaborate with veterinary professionals and research labs to develop herd-specific vaccines tailored to field-isolated pathogens. Investments in diagnostic technologies and integrated vaccine production platforms are enhancing speed-to-market and cost efficiency. Strategic acquisitions and regional partnerships further help key players expand their capabilities and penetrate untapped markets. Additionally, customer education initiatives and digital platforms are being leveraged to increase awareness and facilitate vaccine ordering and delivery.

Key Companies Profiled:

• Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
• Elanco Animal Health
• Phibro Animal Health Corporation
• Ceva Sante Animale
• ACE Laboratory Services (Apiam Animal Health)
• Huvepharma, Inc.
• AniCon Labor GmbH
• Cambridge Technologies
• Dyntec s. r. o
• Hygieia Biological Laboratories
• HIPRA
• Vaxxinova
• sanphar (ipeve)
• Addison Biological Laboratory
• Zoetis (PHARMAQ AS)
• Barramundi Asia Pte Ltd.(UVAXX Asia)
• Kennebec River Biosciences

Key Segments Covered in Autogenous Vaccines Industry Research

Product:

• Bacterial Strain
• Virus Strain

By Animal Type

• Poultry
• Swine
• Fish
• Horses
• Others

End User:

• Veterinary Research Institutes
• Livestock Farming Companies
• Veterinary Clinics and Hospitals

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Autogenous Vaccines Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Disease Epidemiology
• 3.4. Value Chain Analysis
• 3.5. Key Deals and Mergers
• 3.6. PESTLE Analysis
• 3.7. Porter's Five Force Analysis

4. Global Autogenous Vaccines Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Autogenous Vaccines Market Outlook: Strain Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) and Analysis, By Strain Type, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
    • 4.3.3.1. Bacterial Strain
    • 4.3.3.2. Viral Strain
  • 4.3.4. Market Attractiveness Analysis: Strain Type
• 4.4. Global Autogenous Vaccines Market Outlook: Animal Type
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Animal Type, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
    • 4.4.3.1. Poultry
    • 4.4.3.2. Swine
    • 4.4.3.3. Fish
    • 4.4.3.4. Horses
    • 4.4.3.5. Others
  • 4.4.4. Market Attractiveness Analysis: Animal Type
• 4.5. Global Autogenous Vaccines Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 4.5.3.1. Veterinary Clinics and Hospitals
    • 4.5.3.2. Veterinary Research Institutes
    • 4.5.3.3. Livestock Farming Companies
    • 4.5.3.4. Aquaculture Farming
  • 4.5.4. Market Attractiveness Analysis: End User

5. Global Autogenous Vaccines Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Autogenous Vaccines Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Strain Type
  • 6.2.3. By Animal Type
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 6.4.1. Bacterial Strain
  • 6.4.2. Viral Strain
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 6.5.1. Poultry
  • 6.5.2. Swine
  • 6.5.3. Fish
  • 6.5.4. Horses
  • 6.5.5. Others
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 6.6.1. Veterinary Clinics and Hospitals
  • 6.6.2. Veterinary Research Institutes
  • 6.6.3. Livestock Farming Companies
  • 6.6.4. Aquaculture Farming
• 6.7. Market Attractiveness Analysis

7. Europe Autogenous Vaccines Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Strain Type
  • 7.2.3. By Animal Type
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 7.4.1. Bacterial Strain
  • 7.4.2. Viral Strain
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 7.5.1. Poultry
  • 7.5.2. Swine
  • 7.5.3. Fish
  • 7.5.4. Horses
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Veterinary Clinics and Hospitals
  • 7.6.2. Veterinary Research Institutes
  • 7.6.3. Livestock Farming Companies
  • 7.6.4. Aquaculture Farming
• 7.7. Market Attractiveness Analysis

8. East Asia Autogenous Vaccines Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Strain Type
  • 8.2.3. By Animal Type
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 8.4.1. Bacterial Strain
  • 8.4.2. Viral Strain
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 8.5.1. Poultry
  • 8.5.2. Swine
  • 8.5.3. Fish
  • 8.5.4. Horses
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Veterinary Clinics and Hospitals
  • 8.6.2. Veterinary Research Institutes
  • 8.6.3. Livestock Farming Companies
  • 8.6.4. Aquaculture Farming
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Autogenous Vaccines Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Strain Type
  • 9.2.3. By Animal Type
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 9.4.1. Bacterial Strain
  • 9.4.2. Viral Strain
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 9.5.1. Poultry
  • 9.5.2. Swine
  • 9.5.3. Fish
  • 9.5.4. Horses
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Veterinary Clinics and Hospitals
  • 9.6.2. Veterinary Research Institutes
  • 9.6.3. Livestock Farming Companies
  • 9.6.4. Aquaculture Farming
• 9.7. Market Attractiveness Analysis

10. Latin America Autogenous Vaccines Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Strain Type
  • 10.2.3. By Animal Type
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 10.4.1. Bacterial Strain
  • 10.4.2. Viral Strain
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 10.5.1. Poultry
  • 10.5.2. Swine
  • 10.5.3. Fish
  • 10.5.4. Horses
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Veterinary Clinics and Hospitals
  • 10.6.2. Veterinary Research Institutes
  • 10.6.3. Livestock Farming Companies
  • 10.6.4. Aquaculture Farming
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Autogenous Vaccines Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Strain Type
  • 11.2.3. By Animal Type
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Strain Type, 2025-2032
  • 11.4.1. Bacterial Strain
  • 11.4.2. Viral Strain
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal Type, 2025-2032
  • 11.5.1. Poultry
  • 11.5.2. Swine
  • 11.5.3. Fish
  • 11.5.4. Horses
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Veterinary Clinics and Hospitals
  • 11.6.2. Veterinary Research Institutes
  • 11.6.3. Livestock Farming Companies
  • 11.6.4. Aquaculture Farming
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping by Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Phibro Animal Health Corporation,
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Product Types
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Ceva
  • 12.3.3. Boehringer Ingelheim International GmbH
  • 12.3.4. Elanco
  • 12.3.5. Addison Biological Laboratory
  • 12.3.6. Bioveta, a.s.
  • 12.3.7. Vaxxinova
  • 12.3.8. ARKO Laboratories
  • 12.3.9. Dopharma
  • 12.3.10. HIPRA
  • 12.3.11. Cambridge Technologies
  • 12.3.12. IDT Biologika.
  • 12.3.13. HYGIEIA BIOLOGICAL LABORATORIES
  • 12.3.14. Lohmann Breeders
  • 12.3.15. Design Biologix.
  • 12.3.16. Deltamune
  • 12.3.17. Bimeda(R) Biologicals
  • 12.3.18. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations

관련자료